Clinical Trials Browser

Phase 2 × Sarcoma × tumor necrosis factor-alpha, CNGRC fusion protein, human × Clear all

NCT00484341 2018-08-29

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

Phase 2 Completed

Sarcoma